On November 10, 2021 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, reported that management will participate in two upcoming virtual investor conferences (Press release, Harpoon Therapeutics, NOV 10, 2021, View Source [SID1234595123]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at Stifel’s 2021 Virtual Healthcare Conference on Monday, November 15, 2021 at 4 p.m. ET / 1 p.m. PT; and

A pre-recorded fireside chat at Piper Sandler’s 33rd Annual Healthcare Conference will be available on the conference website beginning at 10 a.m. ET / 7 a.m. PT on November 22, 2021. A link to the fireside chat will also become available at the same time on the Harpoon website on the Events page. Harpoon will be participating in 1×1 meetings with investors on Tuesday, November 30, and meetings can be requested exclusively via Piper Sandler.
The webcasts will be available from the Events and Presentations section of the company’s website at View Source and will be archived there shortly after the events.